Target intelligence / Profile preview

H+-translocating pyrophosphatase (H+-PPase)

Target
H+-PPase
Molecular classification
Enzyme, Transporter, Proton pump
01

Overview

H+-translocating pyrophosphatase (H+-PPase), also known as vacuolar H+-translocating pyrophosphatase, is a membrane-bound enzyme that couples the hydrolysis of inorganic pyrophosphate (PPi) to the active transport of protons across biological membranes [1, 5]. It is a unique type of proton pump, distinct from F-, P-, and V-type ATPases, and typically functions as a homodimer composed of a single 70-80 kDa polypeptide [5, 13]. The enzyme is primarily found in the vacuolar membranes of plants and the plasma or organellar membranes of various protozoa, bacteria, and archaea [1, 6]. In plants, it plays a dual role in acidifying the vacuole and maintaining low cytosolic PPi levels to prevent the inhibition of biosynthetic reactions [5, 15]. In parasitic protozoa like Plasmodium falciparum and Leishmania, H+-PPase is essential for maintaining intracellular pH and ion homeostasis [4]. Because H+-PPase is entirely absent in humans and fungi, it represents a promising target for the development of selective antiprotozoal drugs [4, 5]. Compounds such as bisphosphonates and their analogs have been shown to inhibit H+-PPase activity, effectively disrupting the bioenergetics of the parasite [4, 13]. Targeting this enzyme offers a strategy to combat drug-resistant strains of malaria and other neglected tropical diseases [4].

Other names
Vacuolar H+-translocating pyrophosphataseV-PPasemPPaseMembrane-bound inorganic pyrophosphatasePyrophosphate-energized vacuolar membrane proton pumpVHP1AVP1PfVP1
02

Mechanism of action

Inhibition of pyrophosphate hydrolysis and proton translocation, leading to disruption of intracellular pH homeostasis and accumulation of toxic levels of inorganic pyrophosphate.

03

Biological functions

Proton transportPyrophosphate hydrolysispH regulationIon homeostasisPyrophosphate homeostasis
04

Disease associations

Infection
05

Safety considerations

Potential off-target effects on human bone metabolism due to bisphosphonate useChallenges in drug delivery to intracellular parasite compartmentsPotential for drug resistance development in parasites
06

Interacting drugs

Alendronate

6 more in the full profile.

07

Biomarkers

Parasite clearance rateVacuolar pHCytosolic pyrophosphate levels

Beyond the preview

Go deeper on H+-translocating pyrophosphatase (H+-PPase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on H+-translocating pyrophosphatase (H+-PPase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call